Kratom Side Effects: What to Expect and How to Stay Safe

What Are the Most Common Kratom Side Effects?

Grundmann’s (2017) large-scale online survey of US kratom users — 8,049 respondents — found that while the majority reported positive or neutral experiences at moderate doses, a meaningful subset experienced adverse effects, with nausea being the most frequently reported.^[1] Heywood et al.’s 2024 critical review of kratom toxicology reached a similar conclusion across in-vitro, in-vivo, and human case data: typical use of kratom alone presents few acute risks, but alkaloid dose thresholds for adverse effects in humans remain poorly defined, which is why individual titration is the single most effective lever for reducing adverse reactions.^[2]

Commonly reported kratom side effects: ^{[4], [14], [15]}

• Nausea — the most common complaint, particularly at higher doses, on an empty stomach, or for newer users. Nausea is typically dose-dependent and usually resolves within 30–90 minutes, though longer periods of nausea and vomiting have been reported.
• Constipation — occurs with regular use. Mitragynine and 7-hydroxymitragynine activate mu-opioid receptors (MOR) in the gastrointestinal tract, slowing gut motility — the same mechanism responsible for opioid-induced constipation.^[3]
• Dizziness or lightheadedness — more common at higher doses or with rapid position changes. Related to kratom’s alpha-adrenergic receptor activity affecting blood pressure.
• Headache — sometimes related to dehydration. Kratom has mild diuretic properties; users who do not compensate with increased water intake frequently report headaches.
• Dry mouth — reduced salivary gland output is commonly reported, particularly at higher doses.
• Sedation — predominantly at higher doses, especially red vein varieties. At lower doses, many users report stimulant-like effects rather than sedation.
• Sweating — increased perspiration is reported, particularly during the peak effect window.
• Loss of appetite — common with white and green vein varieties at moderate-to-high doses.
• Itching — a classic opioid-receptor-mediated effect; reported most at higher doses.

Additional side effects reported less frequently include irritability, agitation, weight loss, insomnia, flushing, and dehydration.^{[4], [15], [16], [17]}

How Do Kratom Side Effects Depend on Dose?

Kratom’s side effect profile is strongly dose-dependent, and the dose-effect relationship is not simply linear — the character of effects shifts substantially across the dose range, not just the intensity. Smith et al. (2022) analyzed self-reported dose-effect relationships from a sample of US adults with regular kratom use histories, finding that adverse effects became significantly more common above 5 grams per dose.^[4]

The dose-effect curve also means that the most common reason experienced users encounter side effects they previously avoided is dose escalation driven by tolerance. As users take more to maintain the same effect, they push into dose ranges where side effects become significantly more prevalent. This is one of the core reasons tolerance management — including planned breaks — reduces adverse experiences over time. See our Kratom Tolerance Guide for the receptor biology behind this.

It is also worth noting that individual variation is substantial. Swogger et al. (2015) documented through qualitative analysis that kratom users report highly variable experiences at similar doses — a function of individual metabolizer status, body weight, prior substance and mental health history, and strain alkaloid profiles.^[5] Starting low and titrating slowly is not just a general supplement recommendation — it is specifically important with kratom given this variability.

What Do Recent Controlled Human Trials Show About Kratom Side Effects?

Two 2026 controlled trials — both small (40 and 116 participants), short (days to weeks), and using single-source standardized leaf preparations rather than the variable retail products real-world users actually consume — have begun to add controlled-trial evidence to a literature previously based on observational surveys and case reports. Both were pilot-stage studies (a dose-finding pharmacodynamic/pharmacokinetic trial and a safety/tolerability trial), not efficacy trials, and their findings should be read as preliminary safety characterization rather than conclusions about kratom’s overall risk-benefit profile. With those caveats, the adverse-event findings are broadly consistent with what the user-survey literature has reported.

A 2026 pilot dose-finding study in the Journal of Clinical Psychopharmacology, conducted by investigators at the U.S. Food and Drug Administration with the University of Florida and Altasciences, evaluated single oral doses of botanical kratom at 1, 3, 8, 10, and 12 grams in 40 adult volunteers (recreational polydrug users with prior opioid exposure who were otherwise healthy) under double-blind, placebo-controlled conditions.^[6] Somnolence, vomiting, and nausea were the most commonly reported adverse events — the same profile reported across the user-survey literature. Pupillary constriction, an objective marker of mu-opioid receptor activity, was observed at doses of 3 grams and above. No deaths or serious adverse events occurred at any dose tested. Subjective measures of “drug liking,” “good effects,” and “high” increased meaningfully only at the 12-gram dose, supporting the published characterization that abuse-relevant subjective effects emerge at the upper end of the dose range rather than at typical use doses. The authors note that results from this single-source botanical product may not generalize to other kratom-containing products on the market.

Separately, a 2026 randomized placebo-controlled study published in Therapeutic Drug Monitoring — the largest controlled kratom-administration study to date — assessed safety and tolerability of standardized dried kratom leaf powder in 116 kratom-naive healthy volunteers, across single doses (4 escalating dose groups) and 15 consecutive daily doses, with up to 23 days of follow-up (47-day total trial duration); the highest dose tested was 4,000 mg of MitraLeaf leaf powder containing approximately 53 mg of mitragynine.^[7] No serious adverse events or deaths were reported. After single doses, dizziness, nausea, and a feeling of relaxation were the most commonly reported treatment-emergent events; after 15 daily doses, headache, feeling hot, a mild elevation in alanine aminotransferase (ALT, a liver enzyme), and nausea were most common. The mild ALT signal during 15 consecutive days of dosing reinforces the importance of moderation and the liver-monitoring guidance discussed in the long-term-use section below. The authors found no evidence of meaningful abuse potential or withdrawal at the doses studied — a finding consistent with the partial mu-opioid agonism profile characterized in the pharmacology literature, though longer-duration and higher-dose human studies will ultimately be needed to fully characterize dependence risk.

These pilot- and tolerability-stage trials do not resolve questions about long-term safety, real-world product variability, or efficacy for any specific use. They do, however, mark the first controlled-trial confirmation of the broad dose-response, side-effect pattern that the user-survey literature has described for years.

Why Does Kratom Cause Nausea and Constipation?

Gastrointestinal side effects are the most consistently reported category of kratom adverse reactions, and understanding their mechanism helps explain both why they occur and how to manage them.

Nausea has two primary mechanisms with kratom. First, mitragynine and 7-hydroxymitragynine activate opioid receptors in the chemoreceptor trigger zone (CTZ) in the brainstem — the same mechanism responsible for nausea with opioid medications. Second, kratom taken as powder can cause nausea through direct gastric irritation, particularly when taken in large amounts on an empty stomach. This is why toss-and-wash (directly swallowing loose powder) is more likely to cause nausea than capsules and why taking kratom with a small amount of food significantly reduces nausea incidence in many users.

Constipation is a direct consequence of mu-opioid receptor (MOR) activation in the enteric nervous system. Matsumoto et al. established that 7-hydroxymitragynine, even at relatively low doses, significantly inhibits gastrointestinal transit via MOR activation — documenting this as a key pharmacological action of kratom alkaloids.^[3] This effect is essentially identical to opioid-induced constipation: the enteric opioid receptors slow peristalsis and increase water reabsorption from the colon, producing harder, less frequent stools with regular use.

Managing GI side effects practically:

• For nausea: Switch from toss-and-wash powder to capsules; take with a light meal; reduce dose and titrate back up slowly. Ginger tea before dosing is reported by some users to reduce nausea substantially.
• For constipation: Increase water intake to at least 8 glasses per day on days you use kratom; maintain adequate dietary fiber; consider psyllium husk supplementation if constipation persists with regular use. Reducing dose and dosing frequency (e.g., alternating days rather than daily use) is the most effective preventive measure.

What Are the Risks of Long-Term or Daily Kratom Use?

The research base on long-term kratom use in humans is still limited — most useful published data comes from surveys and observational studies, including studies on heavy users where patterns of use may involve higher doses and longer durations than are typical. With that caveat, several concerns associated with prolonged daily use have been documented.

Tolerance and dose escalation: With daily use, tolerance to kratom’s effects develops through mu-opioid receptor downregulation. This leads many daily users to progressively increase their dose over months to years to maintain the same effect. Dose escalation increases exposure to higher-dose side effects and makes the pattern harder to interrupt. This is not unique to kratom — it is a characteristic of any opioid receptor agonist used chronically.

Dependence and discontinuation symptoms: Singh et al. (2014) surveyed regular kratom users in Malaysia and found that those using kratom 3+ times per day for years developed physical dependence with clinically significant discontinuation symptoms including muscle pain, insomnia, irritability, and mood disturbance.^[8] Dependence is somewhat less common in lighter daily users, and those who do develop withdrawal symptoms upon decrease in kratom use report less severity and briefer duration than that for classical opioids. Indeed, expert consensus is that most individuals who report symptoms of kratom dependence find it mild, tolerable, and self-manageable.^[18] However, individual variation indicates that withdrawal symptoms can develop and can be significant, especially for people with substance use problems. See our Kratom Tolerance Breaks Guide for a practical discussion of how to distinguish adjustment from clinical dependence.

Weight changes: Chronic heavy users in several survey studies have reported weight loss, likely related to reduced appetite and gastrointestinal effects of sustained high-dose kratom use.

Darkening of skin: Hyperpigmentation on the cheeks and face has been reported in Southeast Asian users with very long-term heavy use — this appears to be rare in Western users at moderate doses and its mechanism is not fully characterized.

Can Kratom Affect the Liver?

Kratom-associated liver injury is real but rare, and the existing case literature has important characteristics that provide useful context for risk assessment. Prozialeck et al. (2012) noted in their comprehensive pharmacology review that hepatotoxicity had been reported in a small number of cases, almost exclusively in the context of very high-dose use, polypharmacy, or adulterated products.^[9] More recent Drug-Induced Liver Injury Network (DILIN) analysis by Halegoua-DeMarzio and Navarro (2025) names kratom among the leading herbal and dietary supplements implicated in herbal-induced liver injury (HILI) cases over the past decade — still a small fraction of total cases, but well enough documented that ingredient transparency and dose restraint matter.^[10]

A separate concern, documented by Prozialeck et al. (2022), is heavy metal contamination — particularly lead — found in some poorly regulated kratom products in the US market.^[11] Lead-contaminated products could contribute to liver and kidney toxicity independent of kratom’s own alkaloids. This is why third-party Certificate of Analysis (COA) verification and Good Manufacturing Practice (GMP) certification are meaningful quality signals when selecting kratom products.

Warning signs of liver stress: If you develop any of the following while using kratom, stop use and consult a healthcare provider promptly:

• Yellowing of the skin or whites of the eyes (jaundice)
• Dark brown urine
• Severe right-side abdominal pain or tenderness
• Persistent unexplained fatigue combined with any of the above

For the vast majority of users taking moderate doses of quality-tested kratom, liver toxicity is not a significant concern. The risk is substantially elevated by very high doses, adulterated or untested products, co-administration with hepatotoxic substances (alcohol, acetaminophen at high doses), and pre-existing liver conditions. Nonetheless, it is useful to have regular liver function test bloodwork if kratom is taken regularly.

What Drug Interactions Does Kratom Have?

Drug interactions are arguably the highest-priority safety concern for kratom users who take prescription medications, and it is important to acknowledge that research in this area is in its infancy and new interactions will emerge. Kratom alkaloids are metabolized primarily by cytochrome P450 (CYP) enzymes — specifically CYP3A4, CYP2C9, and CYP2D6. Hanapi et al. (2013) demonstrated that mitragynine is an inhibitor of multiple CYP enzymes in vitro, raising the potential for clinically significant interactions with medications that use the same metabolic pathways.^[12]

Furthermore, the 2021 review of kratom alkaloid interactions with enzymes, receptors, and cellular barriers documented that kratom’s alkaloids may interact with P-glycoprotein transporters involved in drug absorption and efflux, adding another potential mechanism for pharmacokinetic interactions.^[13] Below is an incomplete list of kratom-drug interactions.

The essential rule: anyone taking prescription medications — especially those metabolized by the P450 enzyme system — should consult their prescribing provider before using kratom. The inhibition of these enzymes can increase blood levels of other drugs to potentially dangerous levels. This is not only a theoretical concern — it is the same pharmacokinetic mechanism responsible for many known drug-drug interactions with grapefruit juice, which is a well-documented CYP3A4 inhibitor.

Who Is at Highest Risk for Kratom Side Effects?

Kratom is not equally risky for all users. Several characteristics significantly increase the likelihood and severity of adverse effects:

• New users — individual sensitivity varies enormously and cannot be predicted. Starting with one low dose (e.g., 1–2g) and waiting until the next day before considering more is the single most effective way to avoid acute adverse reactions.
• Users of prescription medications — taking multiple medications, particularly CNS depressants or narrow-therapeutic-window drugs, significantly elevates interaction risk.
• Users with pre-existing health conditions — individuals with significant renal, cardiac, and hepatic conditions should not use kratom without first talking to a medical professional.
• People with a history of substance use problems — kratom use for substitution (harm reduction) purposes is well-documented, and users generally report that kratom is helpful for decreasing or ceasing substances perceived to be causing harm (e.g., classical opioids). However, physical dependence on kratom may develop more readily among individuals with a history of substance-related difficulties. Moreover, kratom’s MOR activity can interact with opioid treatment medications (methadone, buprenorphine). Consult a treatment provider before using kratom in this context.
• Pregnant individuals — kratom alkaloids cross the placental barrier. Use during pregnancy is not recommended. See our Kratom and Pregnancy Guide for details.
• Users buying from unverified sources — products without COAs and GMP certification may contain heavy metals, adulterants, or significant dosing inconsistencies that dramatically increase risk independent of kratom’s own pharmacology.

How Do You Minimize Kratom Side Effects?

Most kratom side effects are preventable or significantly reducible through dose discipline and thoughtful use practices. These are the strategies that experienced users and the published user survey literature consistently identify as effective:

1. Start low, titrate slowly — begin at a low dose (e.g., 1g) and increase in small (e.g., 0.5g) increments over several sessions and multiple days. Do not escalate dose because “you don’t feel anything yet” within the first 20–30 minutes. Note that kratom onset varies 15–45 minutes depending on stomach content.
2. Stay hydrated — drink at least 8 oz of water with each dose, plus extra throughout the day on days you use kratom. This reduces headache probability and may partially mitigate constipation.
3. Take with a light meal — a small amount of food slows absorption slightly and significantly reduces nausea incidence. A full meal delays onset substantially; a light snack is the optimal balance.
4. Use capsules if powder causes nausea — kratom capsules eliminate the direct gastric contact with loose powder and reduce nausea substantially for most users who experience it with toss-and-wash.
5. Avoid daily use if possible — even-day or 4–5 days per week use substantially reduces constipation, tolerance, and dependence risk compared to every-day use. See the Kratom Dosage Guide for framework on setting sustainable use patterns.
6. Never combine with CNS depressants — alcohol, benzodiazepines, and opioids are the highest-risk combinations with kratom. There is no safe dose combination; these should be avoided entirely.
7. Buy from lab-tested sources — COA-verified, GMP-certified products eliminate the heavy metal and adulterant risk that is responsible for a disproportionate share of serious adverse events in case reports. Reputable vendors publish batch-specific COAs from independent third-party labs covering alkaloid content, heavy metals, and microbial testing.

Frequently Asked Questions

How long do kratom side effects last?

Most acute side effects — nausea, dizziness, sweating — occur within the first 30–90 minutes after dosing and resolve as effects wear off, typically within 3–5 hours. Constipation is usually a cumulative effect that builds with regular use rather than occurring acutely. If nausea is severe or persists beyond 2–3 hours, this usually indicates the dose was too high for that individual. Reduce your dose at the next use. Serious adverse effects (e.g., jaundice, severe abdominal pain, persistent confusion) warrant medical evaluation regardless of cause.

Is nausea from kratom dangerous?

In most cases, nausea from kratom is an uncomfortable but not dangerous dose-response signal — your body indicating the dose is higher than optimal. It is self-limiting and resolves as kratom effects taper. The practical risk is dehydration if nausea leads to vomiting. Staying seated or lying down and staying hydrated helps. If vomiting is severe or persists, seek medical attention — significant fluid loss from any cause can become medically serious. The simplest prevention is reducing dose the next time; most users find a threshold below which nausea does not occur.

Can kratom cause anxiety or worsen anxiety?

None of this constitutes a recommendation to use kratom for anxiety; clinically diagnosed anxiety disorders should be discussed with a qualified provider. Some users report increased anxiety, nervousness, or restlessness — particularly with white vein varieties, which tend toward more stimulant-dominant profiles. This is more common and probably occurs also at lower doses in individuals who are already prone to stimulant-induced anxiety (e.g., those who are caffeine-sensitive). In Grundmann’s (2017) US survey data, self-reported anxiety reduction is among the most commonly-cited motivations for kratom use, and moderate doses of kratom are reported by many people to be effective for anxiety reduction. High-to-extreme doses are more likely to cause negative emotionality including anxiety, especially the white and green strain varieties. If kratom consistently produces anxiety in your case, lower doses or red vein varieties (which tend to have more sedating profiles) are reported by users to be better tolerated.

Does kratom raise or lower blood pressure?

Kratom has complex cardiovascular effects that vary by dose and individual, and case reports have documented both hypertension and hypotension in the context of kratom use, making a simple characterization difficult. Overall, however, kratom’s potential to increase heart rate and blood pressure is more reliable and significant. Individuals with pre-existing cardiovascular conditions or those taking antihypertensive medications should consult a healthcare provider before using kratom.

Can you overdose on kratom?

Fatal overdoses attributable solely to kratom (without other substances) are exceedingly rare; the vast majority of kratom-related deaths in case literature have involved polypharmacy — co-administration with opioids, benzodiazepines, or other CNS depressants. Moreover, there has been no high-quality causal data to corroborate kratom’s role in fatal overdose. Kratom’s partial agonism at the mu-opioid receptor produces a ceiling on respiratory depression that is substantially lower than full opioid agonists — which is why kratom overdose is treated differently from opioid overdose and naloxone (Narcan) may not fully reverse effects. Very high doses (above 15g) can produce significant toxicity including confusion, extreme sedation, and vomiting — potentially dangerous due to aspiration risk. Do not take kratom at very high doses and never combine with other CNS depressants.

Does kratom cause hair loss?

Hair loss is occasionally reported in forums and user communities but is not well-documented in the clinical literature as a direct kratom side effect. If hair loss is significant or persistent, consult a dermatologist to determine the actual cause.

Are kratom side effects different for men and women?

The published research does not have sufficient sex-stratified data to make definitive statements about differential side effect profiles. There is some evidence from opioid pharmacology research that CYP enzyme activity and opioid receptor distribution differ between biological sexes, which could theoretically produce different pharmacokinetic and pharmacodynamic responses to kratom. Individual variation (body weight, metabolizer status, baseline physiology) may be a much larger driver of side effect differences than sex-based factors at the population level. Kratom use during pregnancy specifically carries distinct concerns and should be discussed with a healthcare provider.

Does kratom cause kidney damage?

Individuals with renal impairment should be cautious with kratom and discuss kratom use with a medical provider. Among healthy individuals, kidney toxicity from kratom alkaloids specifically is not well-documented in the clinical literature. However, the heavy metal contamination issue documented by Prozialeck et al. (2022) — particularly lead — is relevant here: lead is nephrotoxic, and kratom products contaminated with lead would carry kidney damage risk.^[11] This reinforces the importance of purchasing from vendors with independent lab testing for heavy metals. Chronic dehydration from inadequate water intake while using kratom could also contribute to kidney stress over time. The mitigation is straightforward: buy COA-verified products and stay well hydrated.

Can kratom cause depression or mood changes?

The relationship between kratom and mood is dose-dependent and complex. Survey respondents^[1], [14] frequently cite mood-related effects as a motivation for use, though kratom is not a treatment for clinical depression and is not approved by the FDA for any medical use. With chronic daily high-dose use, some users report emotional blunting or dysphoria during non-use periods, consistent with opioid receptor system adaptation; these mood changes during non-use periods are not the same as clinical depression but can feel significant, and typically improve over days to weeks after reducing dose or taking a tolerance break. If mood disturbance is significant or persists, consult a mental health professional — regardless of kratom status.

What should I do if I have a bad reaction to kratom?

For mild reactions (nausea, dizziness, excessive sedation): stop using kratom for that session, stay seated or lie down in a safe position, hydrate, and rest. Most acute reactions resolve within 1–3 hours as the dose clears. Do not take more kratom in an attempt to “balance” the effect. For severe reactions (uncontrollable vomiting, loss of consciousness, difficulty breathing, severe chest pain, significant confusion): call emergency services (911 in the US) immediately and tell them what was taken and in what amount. The Poison Control Center hotline (1-800-222-1222) provides guidance for substance exposures and can advise on whether emergency care is needed for situations that are serious but not immediately life-threatening.

Is it legal to travel with kratom?

Kratom’s legal status varies by country, state, and municipality, and it is prohibited in some jurisdictions. Carrying kratom into a place where it is banned can result in confiscation, fines, or arrest, even if the product was purchased legally where you live. Check the current rules for your destination and for anywhere you transit through before traveling with kratom.

Related Guides

References

1. Grundmann O. (2017). Patterns of kratom use and health impact in the US — results from an online survey. Drug and Alcohol Dependence. [PubMed]
2. Heywood J et al. (2024). Beneficial and adverse health effects of kratom (Mitragyna speciosa): a critical review of the literature. Food and Chemical Toxicology. [PubMed]
3. Matsumoto K, Horie S, Takayama H et al. (2006). Involvement of μ-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine. European Journal of Pharmacology. [PubMed]
4. Smith KE, Feldman AZ, Rogers JM et al. (2022). Searching for a signal: self-reported kratom dose-effect relationships among a sample of US adults with regular kratom use histories. Drug and Alcohol Dependence. [PubMed]
5. Swogger MT, Hart E, Erowid F, et al. (2015). Experiences of Kratom Users: A Qualitative Analysis. Journal of Psychoactive Drugs, 47(5), 360-7. [PubMed]
6. A Pilot, Dose-Finding, Pharmacodynamic and Pharmacokinetic Study of Orally Administered Botanical Kratom (2026). Journal of Clinical Psychopharmacology. [PubMed]
7. Safety and Tolerability of Single and Multiple Daily Oral Doses of Dried Kratom Leaf Powder in a Randomized Trial in Healthy Volunteers (2026). Therapeutic Drug Monitoring. [PubMed]
8. Singh D, Müller CP, Vicknasingam BK (2014). Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence, 139, 132-7. [PubMed]
9. Prozialeck WC, Jivan JK, Andurkar SV. (2012). Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. Journal of the American Osteopathic Association. [PubMed]
10. Halegoua-DeMarzio D, Navarro V. (2025). Challenges in herbal-induced liver injury identification and prevention. Liver International. [PubMed]
11. Prozialeck WC, Fowler A, Edwards J. (2022). Public health implications and possible sources of lead as a contaminant of poorly regulated kratom products in the United States. Toxics. [PubMed]
12. Hanapi NA, Ismail S, Mansor SM. (2013). Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities. Pharmacognosy Research. [PubMed]
13. Hanapi NA, Chear NJ, Azizi J, Yusof SR. (2021). Kratom alkaloids: interactions with enzymes, receptors, and cellular barriers. Frontiers in Pharmacology. [PubMed]
14. Swogger MT, Walsh Z. (2018). Kratom use and mental health: A systematic review. Drug and Alcohol Dependence, 183, 134-140. [PubMed]
15. Swogger MT, Smith KE, Garcia-Romeu A, Grundmann O, Veltri CA, Henningfield JE, Busch LY. (2022). Understanding Kratom Use: A Guide for Healthcare Providers. Frontiers in Pharmacology, 13, 801855. [PubMed]
16. Singh D, Narayanan S, Vicknasingam B. (2016). Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Research Bulletin, 126(Pt 1), 41-46. [PubMed]
17. Smith KE, Panlilio LV, Feldman JD, Grundmann O, Dunn KE, McCurdy CR, Garcia-Romeu A, Epstein DH. (2024). Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults. JAMA Network Open, 7(1), e2353401. [PubMed]
18. Henningfield JE, Chawarski MC, Garcia-Romeu A, Grundmann O, et al. (2023). Kratom withdrawal: Discussions and conclusions of a scientific expert forum. Drug and Alcohol Dependence Reports, 7, 100142. [PubMed]